Fluorouracil (5-FU) Clinical Trials

3 actively recruiting trials across 1 location

▼ -1 trial since August 2026

Pipeline

Phase 2: 1Phase 3: 1Phase 1/2: 1

Top Sponsors

National Cancer Center Hospital East1
Merck Sharp & Dohme LLC1
Gruppo Oncologico del Nord-Ovest1

Indications

Cancer3
Colorectal Cancer2
Gastroesophageal Junction (GEJ) Adenocarcinoma1
Pancreatic Ductal Adenocarcinoma1
Biliary Tract Cancer1

Other2 trials

An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma

Phase 2

FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.

Phase 3

Los Angeles, California1 trial

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

UCLA ( Site 0317)

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.